(AKAN) Akanda - Ratings and Ratios

Akanda Corp. (NASDAQ:AKAN) is a biotechnology company specializing in the cultivation, manufacturing, and global distribution of cannabis-based products for medicinal and wellness purposes. Incorporated in 2021 and headquartered in New Romney, United Kingdom, the company operates through its subsidiaries to deliver high-quality, medicinal-grade cannabis and cannabis-derived products. Akanda Corp. focuses on serving international markets, leveraging its strategic location in the UK to access European and global markets.

From a financial perspective, Akanda Corp. has a market capitalization of $2.41 million USD, with a price-to-book (P/B) ratio of 0.52, indicating the stock is trading at a discount to its book value. The price-to-sales (P/S) ratio of 0.96 suggests the company is valued moderately relative to its revenue. However, the lack of reported earnings (P/E: 0.00) and return on equity (RoE: None) reflects the companys early-stage operational status. Technically, the stock has shown recent weakness, with its last price of $1.44 below the 20-day ($1.66) and 50-day ($1.64) simple moving averages, though it remains above the 200-day SMA of $2.57. The average trading volume of 31,733 shares over the past 20 days and an ATR of 0.11 highlight low liquidity and volatility.